Risk Management and Drug Safety
Agenda: Day Two
V. Institute Good Pharmacovigilance Practices for Effective Risk Management-
Comply with all regulations governing pharmacovigilance
-
Determine the differences between a risk management program and a pharmacovigilance plan
-
Implement an effective and thorough pharmacovigilance plan
-
Determine what to include in a good case report
-
Clarify the role of pharmacoepidemiology in risk management
-
Design and submit effective, timely pharmacoepidemiology studies
Exercise: Case Study on Good Pharmacovigilance Practices
VI. Determine Best Practices for Drug Safety Reporting
-
Code suspected adverse reactions (SADRs) on the basis of MedDRA
-
Write effective, timely PSURS
-
Explore FDA initiative designed to enhance timely collection of SADRs
-
Identify the impact of medication errors
-
Comply with ICH requirements for safety reporting
Exercise: Question and Answer Session on FDA's Rewrite of Drug Safety Reporting Requirements Regulation (The TOME)
VII. Establish an Effective Risk Management Program
-
Identify the benefits of a establishing a risk management program
-
Define FDA terms and analyze final guidances on risk management planning/programs
-
Determine key elements to cover in a risk management program
-
Involve key personnel: qualifications, training, management
-
Appropriately time the submission of your risk management plan
-
Identify new requirements outlined in PDUFA III
Exercise: Case Study on Risk Management Program Solution and Wrap-Up Q&A
Booking Options
This course is available exclusively as an onsite training solution. To discuss a solution that fits your organization's needs, objectives, schedule and budget, contact a PTi Client Solutions Manager at 800-303-8194 or OnSiteSolutions@pti-international.com.